Epidermolysis Bullosa Junctional
📧 Sign up to get email alerts when something new happens for Epidermolysis Bullosa Junctional.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-07-11EMA Authorised: Filsuvez (dry extract from birch bark (DER 5-10 : 1), extraction solvent n-heptane 95% (w/w)) — Chiesi Farmaceutici S.p.A
EMA authorised Filsuvez for epidermolysis bullosa dystrophica and junctional forms; the marketing authorization holder is Chiesi Farmaceutic…